David Forcione is a Gastroenterology physician affiliated with Florida Atlantic University. OpenAlex indexes 125 publications with 6,424 citations (h-index 32); ClinicalTrials.gov lists 1 registered study matched to this name.
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingClinical trials
- Optical Frequency Domain Imaging (OFDI) for Biliary Stricture Imaging
Sponsor: Massachusetts General Hospital
Registered studies on ClinicalTrials.gov where the overall official or a site investigator name-matches this physician, confirmed against known institution/geography. Latest few shown; the full list is part of the full profile.
Industry payments
7 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
7 companies with payments on record in CMS Open Payments (2021 onward), matched to this physician's NPI. The itemized breakdown by company, amount and year is part of the full profile. Why? →
Medicare prescribing footprint (2023)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Anti-infectives
66.3%Fluoroquinolone Antibacterial49.2%Levofloxacin100%Part D≥89 patientsPenicillins with extended spectrum17.1%Amoxicillin-Clavulanate Potass100%Part D≥28 patientsMetabolism & gastrointestinal
22.1%Proton pump inhibitor16.6%Pantoprazole Sodium67%Omeprazole33%Part D<11 patientsBile Acid5.5%Ursodiol100%Part D<11 patientsSensory organs
11.6%Fluoroquinolone Antibacterial11.6%Ciprofloxacin Hcl100%Part D≥23 patients
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- Endoscopic ultrasound-guided gastroenterostomy <i>versus</i> enteral stenting for gastric outlet obstruction: a systematic review and meta-analysis
Therapeutic Advances in Gastroenterology
2024 - Improved Mortality in Necrotizing Pancreatitis with a Multidisciplinary Minimally Invasive Step-Up Approach: Comparison with a Modern Open Necrosectomy Cohort
Journal of the American College of Surgeons
2020 - Endoscopic ultrasound-guided fiducial marker placement in pancreatic cancer: A systematic review and meta-analysis
World Journal of Gastrointestinal Endoscopy
2020
Similar KOLs
Other experts from the same institution or the same specialty.
Brijeshwar Maini, MD
Florida Atlantic University
Mohammad Jahanzeb, MD
Florida Atlantic University
Joseph Forstot, MD
Florida Atlantic University
Tilak Pasala, MD
Florida Atlantic University
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”